{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:15:10Z","timestamp":1791375310884,"version":"4.3.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["KJZD20230923114911023"],"award-info":[{"award-number":["KJZD20230923114911023"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ymthe.2026.02.017","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T15:51:50Z","timestamp":1771084310000},"page":"2611-2620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety and efficacy of hemobeglogene autotemcel(hemo-cel) gene therapy in five patients with transfusion-dependent \u03b2-thalassemia"],"prefix":"10.1016","volume":"34","author":[{"given":"Sixi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9653-1217","authenticated-orcid":false,"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxia","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haigang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8531-7444","authenticated-orcid":false,"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.02.017_bib1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41598-017-00967-2","article-title":"The prevalence of thalassemia in mainland China: evidence from epidemiological surveys","volume":"7","author":"Lai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.02.017_bib2","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/S0140-6736(22)00536-0","article-title":"Thalassaemia","volume":"399","author":"Kattamis","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.02.017_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1586\/ehm.09.74","article-title":"Global burden, distribution and prevention of \u03b2-thalassemias and hemoglobin E disorders","volume":"3","author":"Colah","year":"2010","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.ymthe.2026.02.017_bib4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ymthe.2026.02.017_bib5","doi-asserted-by":"crossref","first-page":"D1063","DOI":"10.1093\/nar\/gkt911","article-title":"Updates of the HbVar database of human hemoglobin variants and thalassemia mutations","volume":"42","author":"Giardine","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.02.017_bib6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.33314\/jnhrc.v20i4.3719","article-title":"Genotype-Phenotype Profile of Beta-thalassemia","volume":"20","author":"Roma","year":"2023","journal-title":"J. Nepal Health Res. Counc."},{"key":"10.1016\/j.ymthe.2026.02.017_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ijlh.13885","article-title":"The hemoglobinopathies, molecular disease mechanisms and diagnostics","volume":"44","author":"Harteveld","year":"2022","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.ymthe.2026.02.017_bib8","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011700","article-title":"The Molecular Basis of -Thalassemia","volume":"3","author":"Thein","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ymthe.2026.02.017_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2015.07.019","article-title":"Iron and oxidative stress in cardiomyopathy in thalassemia","volume":"88","author":"Berdoukas","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ymthe.2026.02.017_bib10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ajh.25103","article-title":"The effect of iron chelation therapy on overall survival in sickle cell disease and \u03b2-thalassemia: A systematic review","volume":"93","author":"Ballas","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymthe.2026.02.017_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100588","article-title":"Challenges of blood transfusions in \u03b2-thalassemia","volume":"37","author":"Shah","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.ymthe.2026.02.017_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.hoc.2022.12.009","article-title":"Hematopoietic Stem Cell Transplantation in Thalassemia","volume":"37","author":"Algeri","year":"2023","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.ymthe.2026.02.017_bib13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ajh.21175","article-title":"Long-term results of survival in patients with thalassemia major treated with bone marrow transplantation","volume":"83","author":"Di Bartolomeo","year":"2008","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymthe.2026.02.017_bib14","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.bbmt.2017.06.004","article-title":"A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for \u03b2-Thalassemia","volume":"23","author":"Chaudhury","year":"2017","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.ymthe.2026.02.017_bib15","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ajh.25909","article-title":"Gene therapies for transfusion dependent \u03b2-thalassemia: Current status and critical criteria for success","volume":"95","author":"Soni","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymthe.2026.02.017_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 Gene Editing for Sickle Cell Disease and \u03b2-Thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.017_bib17","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa2309673","article-title":"Exagamglogene Autotemcel for Transfusion-Dependent \u03b2-Thalassemia","volume":"390","author":"Locatelli","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.017_bib18","series-title":"Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and Other Body Fluid Proteins","first-page":"275","article-title":"Embryonic and Fetal Human Hemoglobins: Structures, Oxygen Binding, and Physiological Roles","author":"Manning","year":"2020"},{"key":"10.1016\/j.ymthe.2026.02.017_bib19","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","article-title":"Gene Therapy in Patients with Transfusion-Dependent \u03b2-Thalassemia","volume":"378","author":"Thompson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.017_bib20","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/S0140-6736(24)01884-1","article-title":"Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype \u03b2-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial","volume":"404","author":"Kwiatkowski","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.02.017_bib21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.stem.2024.04.021","article-title":"Modified lentiviral globin gene therapy for pediatric \u03b20\/\u03b20 transfusion-dependent \u03b2-thalassemia: A single-center, single-arm pilot trial","volume":"31","author":"Li","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2026.02.017_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/hum.2020.204","article-title":"Restoration of \u03b2-Globin Expression with Optimally Designed Lentiviral Vector for \u03b2-Thalassemia Treatment in Chinese Patients","volume":"32","author":"Ouyang","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.017_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41591-018-0301-6","article-title":"Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent \u00df-thalassemia","volume":"25","author":"Marktel","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.02.017_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa2113206","article-title":"Betibeglogene Autotemcel Gene Therapy for Non\u2013\u03b20\/\u03b20 Genotype \u03b2-Thalassemia","volume":"386","author":"Locatelli","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.017_bib25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.omtm.2023.05.003","article-title":"Evaluation of diversity indices to estimate clonal dominance in gene therapy studies","volume":"29","author":"Corre","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.02.017_bib26","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1182\/blood-2023-188499","article-title":"Gene Therapy of Transfusion-Dependent \u03b2-Thalassemia Patients with Quick Engraftment of Reinfused Hematopoietic Stem Cells: An Investigator-Initiated Trial of KL003","volume":"142","author":"Huang","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.02.017_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41591-021-01554-9","article-title":"Lentiviral globin gene therapy with reduced-intensity conditioning in adults with \u03b2-thalassemia: a phase 1 trial","volume":"28","author":"Boulad","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.02.017_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.stem.2011.02.003","article-title":"Prostaglandin E2 Enhances Human Cord Blood Stem Cell Xenotransplants and Shows Long-Term Safety in Preclinical Nonhuman Primate Transplant Models","volume":"8","author":"Goessling","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2026.02.017_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcmd.2014.02.002","article-title":"Inhibition of DPP4\/CD26 and dmPGE2 treatment enhances engraftment of mouse bone marrow hematopoietic stem cells","volume":"53","author":"Broxmeyer","year":"2014","journal-title":"Blood Cells. Mol. Dis."},{"key":"10.1016\/j.ymthe.2026.02.017_bib30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMoa1609677","article-title":"Gene Therapy in a Patient with Sickle Cell Disease","volume":"376","author":"Ribeil","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.02.017_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajh.26741","article-title":"Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB -206 study","volume":"98","author":"Kanter","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymthe.2026.02.017_bib32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/bmt.2010.186","article-title":"What is the minimum level of donor chimerism necessary to sustain transfusion independence in thalassaemia?","volume":"46","author":"Alfred","year":"2011","journal-title":"Bone Marrow Transpl."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:32:18Z","timestamp":1781829138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1525001626001036"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.017","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of hemobeglogene autotemcel(hemo-cel) gene therapy in five patients with transfusion-dependent \u03b2-thalassemia","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}